A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
- Enterprise Secondments
- Social Enterprise Awards
- Translational Research Office Administered Funds
- More funding opportunities (a UCL login is required to access this part of the site)
UCL Enterprise works with all academic disciplines to promote knowledge exchange and to facilitate engagement with the wider world. Currently we receive funding from the Higher Education Innovation Fund (HEIF), the Engineering and Physical Sciences Research Council (EPSRC) and the Medical Research Council (MRC) to help achieve our goals.
EPSRC funding has thus far supported a knowledge-exchange programme with a wide-range of partners in a variety of ways. The programme aims to link high technology and intellectual strength; attract highest-skilled people and partners who can innovate and turn innovation into commercial and social opportunities.
As of 1 October 2012 the EPSRC has allocated just under £4.5 million to extend this partnership with UCL in the form of an Impact Acceleration Account (IAA). The extended funding program now includes support for East London’s Tech City, Secondments, Discovery to Use grants, and the development of several strategic hubs.
MRC funding supports translational research run through the Translational Research Office. The TRO aims to enhance the translational culture within UCL and to facilitate the translation of UCL’s basic and clinical research into therapies, techniques and medical products with therapeutic value. These aims are achieved through interacting with investigators, identifying translatable opportunities, advising on project progression strategy and accessing suitable funding. The TRO also provides project management expertise to steer programmes towards practical endpoints.
HEIF funding supports the provision of “Proof of Concept” (PoC) funds, administered through UCL Business and the Knowledge Transfer Champion initiative. PoC funds support generation of data for commercialisation, e.g. prototype production or pre-clinical activities. Knowledge Transfer Champions have as their main aim to encourage knowledge transfer within UCL. In addition, HEFCE together with UnLtd supports an initiative for social enterprise awards. This scheme aims to provide support to both academics and students looking to set up social enterprises, please find further information here.